Premium
An alert to Latin America: Current human papillomavirus vaccination trends highlight key barriers to successful implementation
Author(s) -
NogueiraRodrigues Angelica,
Bukowski Alexandra,
Paulino Eduardo,
St. Louis Jessica,
Barrichello Adriana,
Sternberg Cinthya,
Gifoni Markus A. C.,
Luciani Silvana,
Goss Paul E.
Publication year - 2017
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.30647
Subject(s) - medicine , papanicolaou stain , latin americans , human papillomavirus , vaccination , vigilance (psychology) , low and middle income countries , human papillomavirus vaccine , environmental health , cervical cancer , economic growth , developing country , virology , cancer , political science , psychology , neuroscience , law , economics , gardasil
Human papillomavirus vaccine programs run the risk of repeating the problems associated with Papanicolaou testing programs in low‐income and middle‐income countries: an efficient, life‐saving tool that unfortunately is underused for cancer prevention. There is a great need for vigilance in the ongoing implementation of the human papillomavirus vaccine in Latin America.